跳至主要内容
临床试验/NCT05693116
NCT05693116招募中不适用

Survival and Prognostic Factors of Squamous Cell Carcinoma of the Nasal Vestibule: a Multi-centre Study

Istituto Clinico Humanitas6 个研究点 分布在 3 个国家目标入组 300 人开始时间: 2022年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
300
试验地点
6
主要终点
Survival

研究概览

简要总结

The goal of this observational study is to learn about survival and prognostic factors in patients who underwent surgical treatment for primary squamous cell carcinoma of the nasal vestibule. The main questions it aims to answer are:

  • what is the prognosis of patients affected by squamous cell carcinoma of the nasal vestibule?
  • are there any specific factors that could influence prognosis?
  • is it possible to elaborate a new staging system, able to overcome the limitations of the currently used ones? Data about patients, tumour and type of surgery performed will be collected. Participants will be followed-up for a minimum 6 months period after surgery.

详细描述

This study will address the survival of patients with squamous cell carcinoma of the nasal vestibule (NV-SCC), and it will analyze factors influencing it.

In particular, apart from demographic features of the patient, data regarding the origin of the tumour and its extension will be collected and the lesion will be restaged according the the three classification systems used at present (Wang's classification, AJCC for nasal cavity cancers, AJCC for non-melanomatous skin cancer of head and neck region), given the current controversy regarding the best staging system. Furthermore data related to the surgery and the final histology will be collected.

All collected data will be analyzed in order to investigate any possible factor related to overall survival, disease specific survival and disease free survival.

Patients will be followed for a minimum of 6 months up to 5 years after surgery.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • diagnosis of squamous cell carcinoma of the nasal vestibule
  • underwent upfront surgical treatment with curative intent
  • availability of clinical and radiological data for cT reassessment
  • availability of histological samples for pT reassessment
  • follow-up of at least 6 months after surgery.

排除标准

  • patients initially referred for disease persistence or recurrence
  • patients affected by tumour involving the nasal vestibule but originating from other sites (eg. nasal cavities, skin of the nasal pyramid or upper lip)

结局指标

主要结局

Survival

时间窗: From time of enrollment to event (death, recurrence) up to 60 months.

Disease Specific Survival

次要结局

  • Factors influencing survival (demographics, tumour-related, surgery-related)(From time of enrollment to event (death, recurrence) up to 60 months.)

研究者

发起方
Istituto Clinico Humanitas
申办方类型
Other
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验